文献速递心律失常血脂与心血管预防

慢性阻塞性肺疾病与心房颤动:跨学科视角

Chronic obstructive pulmonary disease and atrial fibrillation: an interdisciplinary perspective.
PubMed 文献 · Eur Heart J · 2021-01-01

综述指出房颤患者中慢阻肺患病率约25%,二者共享危险因素且慢阻肺增加房颤患者总体疾病负担与死亡。慢阻肺急性加重可短暂增加房颤风险,观察性数据显示慢阻肺促进房颤进展、增加电复律后复发并降低导管消融疗效,但治疗慢阻肺能否改善房颤结局尚不明确。

要点

  • 房颤患者中慢阻肺患病率约25%,应关注二者共存。
  • 慢阻肺急性加重可短暂增加房颤风险。
  • 观察性数据显示慢阻肺增加电复律后及导管消融后房颤复发。

核心结论

  • 慢阻肺在房颤患者中高度流行并与不良结局相关,但治疗慢阻肺能否改善房颤结局尚不明确。

研究设计与样本

  • 本文为跨学科视角的综述,未报告系统检索范围与样本量。

主要发现

  • 房颤患者中慢阻肺患病率估计约为25%。
  • 慢阻肺急性加重通过缺氧、炎症、β2受体激动剂使用增加及自主神经变化等机制短暂增加房颤风险。
  • 观察性数据显示慢阻肺促进房颤进展、增加电复律后房颤复发并降低导管消融疗效。
  • 非随机研究提示慢阻肺与电复律及导管消融后房颤复发增加相关。

临床怎么用

  • 房颤患者应通过肺功能、利钠肽和超声心动图等检查鉴别慢阻肺与心衰等呼吸困难原因。
  • 房颤合并慢阻肺的管理需要电生理/心内科医生与呼吸科医生紧密协作。

局限性

  • 治疗慢阻肺是否改善房颤结局尚不明确。
  • 用于确定慢阻肺严重程度并指导房颤患者治疗的指标尚不明确。
  • 需前瞻性队列研究确认慢阻肺与房颤的关系及常规筛查的必要性与成本效益。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

Chronic obstructive pulmonary disease (COPD) is highly prevalent among patients with atrial fibrillation (AF), shares common risk factors, and adds to the overall morbidity and mortality in this population. Additionally, it may promote AF and impair treatment efficacy. The prevalence of COPD in AF patients is high and is estimated to be ∼25%. Diagnosis and treatment of COPD in AF patients requires a close interdisciplinary collaboration between the electrophysiologist/cardiologist and pulmonologist. Differential diagnosis may be challenging, especially in elderly and smoking patients complaining of unspecific symptoms such as dyspnoea and fatigue. Routine evaluation of lung function and determination of natriuretic peptides and echocardiography may be reasonable to detect COPD and heart failure as contributing causes of dyspnoea. Acute exacerbation of COPD transiently increases AF risk due to hypoxia-mediated mechanisms, inflammation, increased use of beta-2 agonists, and autonomic changes. Observational data suggest that COPD promotes AF progression, increases AF recurrence after cardioversion, and reduces the efficacy of catheter-based antiarrhythmic therapy. However, it remains unclear whether treatment of COPD improves AF outcomes and which metric should be used to determine COPD severity and guide treatment in AF patients. Data from non-randomized studies suggest that COPD is associated with increased AF recurrence after electrical cardioversion and catheter ablation. Future prospective cohort studies in AF patients are needed to confirm the relationship between COPD and AF, the benefits of treatment of either COPD or AF in this population, and to clarify the need and cost-effectiveness of routine COPD screening.

来源:Eur Heart J,查看原文。版权归原作者所有。

引用

  1. Simons SO, Elliott A, Sastry M, et al. Chronic obstructive pulmonary disease and atrial fibrillation: an interdisciplinary perspective. Eur Heart J. 2021. PMID: 33206945. doi:10.1093/eurheartj/ehaa822

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。